Table 1.

Clinical and demographic characteristics of the study population

Parameter		n (%)
Age	<20	26 (7.3)
	20–39	208 (58.6)
	40–59	107 (30.1)
	≥60	14 (3.9)
	Total	355
Gender	F	236 (66.5)
	M	119 (33.5)
	Total	355
On HAART	Yes	201 (56.6)
	No	154 (43.4)
	Total	355
Sleeping under ITN	Yes	280 (78.9)
	No	75 (21.1)
	Total	355
Mean (±SD) duration of HIV	HAART	4.4 ± 2.5
	Naïve	1.2 ± 3.4
	Total	3.0 ± 3.3
CD4+ T cell counts	<200	40 (11.3)
	200–499	151 (42.5)
	≥500	164 (46.2)
	Total	355
On prophylaxis with cotrimoxazole	Yes	234 (65.9)
	No	121 (34.1)
	Total	355